alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 99.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report of OCTuS, Inc. (the Company), on Form 10-QSB for the quarter ending March 31, 2003 as filed with the Securities and Exchange Commission (the Report), I, John Belden, Chief Executive Officer and Principal Financial Officer of the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §  1350), that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/ s /  John Belden

John Belden
Chief Executive Officer and Principal Financial Officer

May 7, 2003
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 1651 Introduced in Senate (IS)]

108th CONGRESS
  1st Session
                                S. 1651

                 For the relief of Gustav F.K. Wallner.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 24, 2003

  Mr. Stevens introduced the following bill; which was read twice and 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
                 For the relief of Gustav F.K. Wallner.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PERMANENT RESIDENCE.

    Notwithstanding any other provision of law, for purposes of the 
Immigration and Nationality Act (8 U.S.C. 1101 et seq.), Gustav F.K. 
Wallner shall be held and considered to have been lawfully admitted to 
the United States for permanent residence as of the date of the 
enactment of this Act upon payment of the required visa fee.

SEC. 2. REDUCTION OF NUMBER OF AVAILABLE VISAS.

    Upon the granting of permanent residence to Gustav F.K. Wallner as 
provided in this Act, the Secretary of State shall instruct the proper 
officer to reduce by 1 during the current fiscal year the total number 
of immigrant visas available to natives of the country of the alien's 
birth under section 203(a) of the Immigration and Nationality Act (8 
U.S.C. 1153(a)).
                                 <all>
```
EXHIBIT
32.2




CERTIFICATION
OF CHIEF FINANCIAL OFFICER




PURSUANT
TO 18 U.S.C. SECTION 1350,




AS
ADOPTED PURSUANT TO




SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Amendment No. 2
on Form 10-KSB/A to the Annual Report of Scivanta Medical Corporation (the
“Company”) on Form 10-KSB for the fiscal year ended October 31, 2008, as filed
with the Securities and Exchange Commission (the “Report”), I, Thomas S.
Gifford, Executive Vice President, Chief Financial Officer and Secretary of the
Company, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to
§906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:




(1)           the
Report fully complies with the requirements of §13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, 15 U.S.C. §78m or 78o(d), and,




(2)           the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.




June
      22, 2009
            By:
            /s/ Thomas S. GiffordThomas
      S. GiffordExecutive
      Vice President,Chief
      Financial Officer andSecretary
#### Donald W. GREEN, Plaintiff-Appellant, v. Donald Ray SHIVER; Jones County; Marlene Skiver; Jones-Onslow EMC; Larry Patrick, Defendants-Appellees.

No. 03-1424.

United States Court of Appeals, Fourth Circuit.

Submitted Aug. 20, 2003.

Decided Aug. 28, 2003.

Donald W. Green, Appellant Pro Se. Mark Allen Davis, Womble, Carlyle, Sandridge & Rice, Raleigh, North Carolina; Cynthia Marie Currin, Crisp, Page & Currin, Raleigh, North Carolina, for Appellees.

Before NIEMEYER and TRAXLER, Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by unpublished PER CURIAM opinion.

PER CURIAM.

Donald W. Green appeals the district court’s order denying relief on his 42 U.S.C. § 1983 (2000) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. *See Green v. Shiver,*No. CA-02-92-4-H(3) (E.D.N.C. Mar. 5, 2003). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
*This order and judgment is not binding precedent, except under the

doctrines of law of the case, res judicata, and collateral estoppel. The court

generally disfavors the citation of orders and judgments; nevertheless, an order

and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.

F I L E D

United States Court of Appeals

Tenth Circuit

December 15, 2005

Clerk of Court

UNITED STATES COURT OF APPEALS

TENTH CIRCUIT

JESUS FAJARDO, 

Petitioner, No. 05-9516

v. (BIA No. A70-688-340)

ALBERTO GONZALES, Attorney

General,

(Petition for Review)

Respondent.

 

ORDER AND JUDGMENT*

Before EBEL, McKAY, and HENRY, Circuit Judges. 

After examining the briefs and appellate record, this panel has determined

unanimously to honor the parties’ request for a decision on the briefs without oral

argument. See Fed. R. App. P. 34(f). The case is therefore submitted without

oral argument.

Petitioner is an alien from El Salvador. In 1997, an immigration law judge

(“ILJ”) found that he should be deported, denied his applications for asylum and

withholding of deportation, and granted him voluntary departure. Petitioner
-2-

appealed the ILJ’s decision to the Board of Immigration Appeals (“BIA”) which

dismissed his appeal on August 10, 1999. On July 19, 2000, Petitioner filed a

motion to reopen his deportation proceedings which the BIA also denied. 

Subsequently, On February 9, 2005, Petitioner filed a second motion to reopen

with the BIA. The BIA denied that motion as being numerically barred by its

regulations. Petitioner now files the instant petition for a review of the BIA’s

denial of his second motion to reopen. 

We review the BIA’s denial of a motion to reopen for an abuse of

discretion. Infanzon v. Ashcroft, 386 F.3d 1335, 1362 (10th Cir. 2004). The

Board “abuses its discretion when its decision provides no rational explanation,

inexplicably departs from established policies, is devoid of any reasoning, or

contains only summary or conclusory statements.” Id. (internal quotation marks

and citation omitted). Generally, the BIA has “broad discretion” to grant or deny

a motion to reopen. See INS v. Doherty, 502 U.S. 314, 323 (1992) (quoting INS v.

Rios-Pineda, 471 U.S. 444, 449 (1985)). 

There is nothing in this case indicating that the BIA abused its discretion

when it denied Petitioner’s second motion to reopen. In its order, the BIA

explained, “[T]he motion to reopen exceeds the numerical limitations for motions

to reopen and will be denied.” A.R. at 2; see 8 C.F.R. § 1003.2(c)(2). The order

further explained that the BIA is generally limited to reviewing only one motion
-3-

to reopen, except in certain circumstances not present in Petitioner’s case.

Based on our review of the facts and relevant law surrounding this issue,

we determine that the BIA did not abuse its discretion when it denied Petitioner’s

second motion to reopen. 

Accordingly, the BIA’s decision is AFFIRMED. 

Entered for the Court

Monroe G. McKay

Circuit Judge
**EXHIBIT 10.5**

 

**Sirna Therapeutics, Inc.**

**2005 Amended Director Compensation Plan**

 

The director compensation package for members of the Board of Directors (“the Board”) of Sirna Therapeutics, Inc. (the “Company”) is as follows: 

 

**1. Cash Retainer.** Each director shall receive a cash retainer of $20,000 per year of service (the “Annual Retainer”). Alldirectors who join the Board after June 14, 2005 shall receive the Annual Retainer upon joining the Board and on each subsequent anniversary of continued service. Directors on the Board on June 14, 2005 shall receive the Annual Retainer asof that date. 

 

**2. Meeting Fee.** Each director shall receive $1,000 foreach Board or committee meeting attended in person (the “Meeting Fee”) and $500 for each Board or committee meeting attended by telephone, with the exception that directors who participate in Audit Committee meetings by telephone shall bepaid $1,000 for each meeting so attended. 

 

**3. Chairperson Retainer.** Eachdirector who serves as chairperson of a committee of the Board, with the exception of a director who serves as chairperson of the Board or of the Audit Committee, shall receive a cash retainer in addition to the Annual Retainer of $10,000. Adirector who serves as chairperson of the Board or of the Audit Committee shall receive a cash retainer of $15,000 in addition to the Annual Retainer. 

 

**4. Stock Options.** All directors who join the Board after June 14, 2005, shall be offered an option to purchase 30,000 shares of the Company’s commonstock upon joining the Board (the “Initial Option”) and an option to purchase 10,000 shares of the Company’s common stock upon each anniversary of continued service (the “Annual Option”). The Initial Option shall vest intwenty-four (24) equal monthly installments upon the completion of each of the first twenty-four months of service. The Annual Option shall vest in twelve (12) equal monthly installments upon the completion of each month of service overthe course of one year. Directors on the Board on June 14, 2005 shall be granted the Annual Option commencing in January 2006. 

 

**5. Exercise after Separation.** Subject to Section 6 below, upon separation from the Board, a director shall have three (3) years from the date ofseparation in which to exercise vested options. 

 

**6. Election to Convert.**A director may elect to convert the Annual Retainer and/or any payments due to the director as a result of service as a chairperson into a fully vested option with a face value equal to three (3) times the amount to be converted. 

 

**7. Acceleration.** Outstanding options held by a director shall become immediately fullyvested in the following circumstances: (i) death of such director; (ii) permanent disability of such director; (iii) change of control of the Company; or (iv) termination without cause of such director, all as described in theCompany’s 2005 Performance Incentive Plan or successor plan. 

 

**8.Amendments.** Any future change to the plan for director compensation shall go into effect as of the date of the stockholder meeting following the date the change is approved by the Board.
Exhibit
23.1





Consent
of Independent Registered Public Accounting Firm





The Board
of Directors


NexCen
Brands, Inc.:




We consent to the incorporation by
reference in the registration statements (Nos. 333-91369, 333-52220, 333-128062,
333-52222, 333-139078) on Form S-8of NexCen Brands, Inc. and subsidiaries
(formerly Aether Holdings, Inc.) of our report datedMarch26, 2010, with respect to the consolidated
balance sheets of NexCen Brands, Inc. and subsidiaries as of December 31,
2009and 2008, and the related consolidated statements of
operations, stockholders’deficit, and cash flows forthe years then ended, which report appears in the December
31, 2009annual report on Form 10-K of NexCenBrands,
Inc.




As
discussed in Note 1 to the consolidated financial statements, the Company faces
certain liquidity uncertainties that raise substantial doubt about its ability
to continue as a going concern. Management’s plans in regard to these matters
are described in Note 1. The consolidated financial statements do not include
any adjustments that might result from the outcome of this
uncertainty.





/s/ KPMG
LLP





New York,
New York


March 26,
2010
#### PATRICK WALSH v. BETHLEHEM STEEL CORPORATION.

January 28, 1987.

Petition for certification denied. (See 214 *N.J.Super.*6)
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     ART. 5 FDS FOR 1ST QUARTER 10-Q
</LEGEND>
<CIK>                         0000891531                    
<NAME>                        SHERI WEBB
<MULTIPLIER>                  1,000
<CURRENCY>                    1
       
<S>                            <C>
<PERIOD-TYPE>                  3-MOS
<FISCAL-YEAR-END>              JUN-30-1999
<PERIOD-START>                 JUL-1-1998
<PERIOD-END>                   SEP-30-1998
<EXCHANGE-RATE>                1
<CASH>                         21,400
<SECURITIES>                   0
<RECEIVABLES>                  283,400
<ALLOWANCES>                   0
<INVENTORY>                    117,300
<CURRENT-ASSETS>               455,900
<PP&E>                         517,300
<DEPRECIATION>                 144,000
<TOTAL-ASSETS>                 1,613,200
<CURRENT-LIABILITIES>          522,600
<BONDS>                        0
<PREFERRED-MANDATORY>          0
<PREFERRED>                    0
<COMMON>                       400
<OTHER-SE>                     (20,200)
<TOTAL-LIABILITY-AND-EQUITY>   1,613,200
<SALES>                        339,100
<TOTAL-REVENUES>               339,100
<CGS>                          291,700
<TOTAL-COSTS>                  291,700
<OTHER-EXPENSES>               50,400
<LOSS-PROVISION>               0
<INTEREST-EXPENSE>             22,100
<INCOME-PRETAX>                (24,100)
<INCOME-TAX>                   0
<INCOME-CONTINUING>            (28,500)
<DISCONTINUED>                 0
<EXTRAORDINARY>                0
<CHANGES>                      0
<NET-INCOME>                   (28,500)
<EPS-PRIMARY>                  (0.77)
<EPS-DILUTED>                  (0.77)
        



</TABLE>
EXHIBIT 31

                           CRUSADE MANAGEMENT LIMITED
                            SECTION 302 CERTIFICATION

I, Steve McKerihan, certify that:

1. I have reviewed this annual report on Form 20-F,  and all reports on Form 6-K
containing  distribution  or  servicing  reports  filed in  respect  of  periods
included in the year covered by this annual report, of Crusade Global Trust No.2
of 2003;

2. Based on my knowledge,  the  information in these reports,  taken as a whole,
does not  contain  any untrue  statement  of a material  fact or omit to state a
material  fact  necessary  to  make  the  statements   made,  in  light  of  the
circumstances  under which such  statements  were made, not misleading as of the
last day of the period covered by this annual report;

3. Based on my knowledge,  the distribution or servicing information required to
be provided to the trustee by the servicer under the pooling and  servicing,  or
similar,  agreements,  for  inclusion  in these  reports  is  included  in these
reports;

4. I am responsible for reviewing the activities performed by the servicer under
the pooling and  servicing,  or similar,  agreements and based upon my knowledge
and the annual  compliance  review required under that agreement,  and except as
disclosed in the reports,  the servicer has fulfilled its obligations under that
agreement; and

5. The reports disclose all significant  deficiencies relating to the servicer's
compliance with the minimum  servicing  standards based upon the report provided
by an independent  public  accountant,  after  conducting a review in compliance
with the Uniform  Single  Attestation  Program for  Mortgage  Bankers or similar
procedure,  as set forth in the pooling and servicing,  or similar,  agreements,
that is included in these reports.

In giving the  certifications  above,  I have  reasonably  relied on information
provided to me by the following unaffiliated parties:_

Perpetual Trustees Consolidated Limited

                                                 /S/ S. McKerihan
                                                -----------------------------
                                                S. McKerihan
                                                CFO - Crusade Management Limited

                                                Date:  March 25, 2004
[Federal Register Volume 75, Number 206 (Tuesday, October 26, 2010)]
[Notices]
[Pages 65639-65640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-27055]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the

[[Page 65640]]

provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; U.S.-Bilateral Collaborative 
Research Partnerships (CRP) on the Prevention of HIV/AIDS and Co-
morbidities (R21).
    Date: December 1-2, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Regency, Rockville, MD 20852.
    Contact Person: Eugene R. Baizman, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892, 301-402-1464, <a href="/cdn-cgi/l/email-protection#593c3b6b6a6e3c19373031773e362f"><span class="__cf_email__" data-cfemail="a1c4c3939296c4e1cfc8c98fc6ced7">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 20, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-27055 Filed 10-25-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                          10,347
<INT-BEARING-DEPOSITS>                           4,485
<FED-FUNDS-SOLD>                                 5,208
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     79,891
<INVESTMENTS-CARRYING>                             507
<INVESTMENTS-MARKET>                               486
<LOANS>                                        281,689
<ALLOWANCE>                                      2,193
<TOTAL-ASSETS>                                 400,293
<DEPOSITS>                                     355,728
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                              3,532
<LONG-TERM>                                      5,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        16,017
<OTHER-SE>                                      20,016
<TOTAL-LIABILITIES-AND-EQUITY>                 400,293
<INTEREST-LOAN>                                  5,273
<INTEREST-INVEST>                                1,315
<INTEREST-OTHER>                                   308
<INTEREST-TOTAL>                                 6,896
<INTEREST-DEPOSIT>                               3,686
<INTEREST-EXPENSE>                               3,826
<INTEREST-INCOME-NET>                            3,070
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  2,920
<INCOME-PRETAX>                                    752
<INCOME-PRE-EXTRAORDINARY>                         500
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       500
<EPS-BASIC>                                        .40
<EPS-DILUTED>                                      .39
<YIELD-ACTUAL>                                       0
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                     0
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                    0
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
# Deep Space Food Challenge Finalists 2023

Deep Space Food Challenge (2023) – Two Challenge finalists prepare samples of their food system to share at the Phase 2 winner’s announcement event in Brooklyn, New York. 

                    -  Facebook PinterestX
-  LinkedIn Emailhttps://www.nasa.gov/image-detail/deep-space-food-challenge-1/Copy URL to clipboard>DownloadShareTags- Centennial Challenges
Image CreditNASASize2048x1536pxThe National Aeronautics and Space Administration
NASA explores the unknown in air and space, innovates for the benefit of humanity, and inspires the world through discovery.
- About NASA's Mission
Join Us- Home
- News & Events
- Multimedia
- NASA+
- Missions
- Humans in Space
- Earth & Climate
- The Solar System
- The Universe
- Science
- Aeronautics
- Technology
- Learning Resources
- About NASA
- NASA en Español
Follow NASA-   
-   
-   
-   
- 
- More NASA Social Accounts
- NASA Newsletters
- Sitemap
- For Media
- Privacy Policy
- FOIA
- No FEAR Act
- Office of the IGBudget & Annual Reports
Agency Financial Reports
Contact NASA
Accessibility
-  									Page Last Updated:								  								Jun 20, 2023								 
-  									Page Editor:								  									Beth Ridgeway								 
-  								Responsible NASA Official:							  								Abigail Bowman